Sale

Proteasome Inhibitors Market

Global Proteasome Inhibitors Market Size, Share, Forecast: By Product: Velcade, Kyprolis, Ninlaro, Others; Regional Analysis; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, Key Indicators for Demand, Key Indicators for Price; Value Chain Analysis; Competitive Landscape; Key Trends and Developments in the Market; 2024-2032

Global Proteasome Inhibitors Market Outlook

The global proteasome inhibitors market is expected to grow at a CAGR of 8.6% in the forecast period of 2024-2032 to reach nearly USD 3.77 billion by 2032.

 

Global Proteasome Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The industry is expanding due to the development in the research sector, providing treatment for multiple myeloma and drugs to treat pancreatic cancer. North America held the largest market share in 2018, however, it is anticipated to witness a slower growth during the forecast period because of the rising number of substitutes approved by the government, especially in the United States.

 

Market Segmentation

Proteasome inhibitors help in the prevention or delay in the degradation of proapoptotic factors. It facilitates the programmed cell death that ultimately cures the disease.

 

Global Proteasome Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

The various product types of proteasome inhibitors are:

  • Velcade
  • Kyprolis
  • Ninlaro
  • Others

The EMR report looks into the regional proteasome inhibitors markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.

 

Market Analysis

The global proteasome inhibitors market is being driven by the enormous unmet demand and expanding applications of proteasome inhibitors in the treatment of blood cancer and primarily myeloma. The industry is further aided by the rising prevalence of cancer, globally, as proteasome has proved to be efficient for treating cancer indications. The ability of the drug is prompting vendors to conduct studies on the therapeutics effects of the product on solid tumours, hence, promoting the growth of the industry. The other factor leading to the growth of the proteasome inhibitors market is the application of proteasome inhibitors in the treatment of various health conditions. North America accounted for the largest industry share in 2018 due to the high incidences of multiple myeloma and non-Hodgkin’s lymphoma in the region. However, Europe and Asia, are expected to witness a significant growth during the forecast period owing to increased incidences of myeloma and rising sales of proteasome inhibitors in the regions.

 

Global Proteasome Inhibitors Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Competitive Landscape

The report presents a detailed analysis of the following key players in the global proteasome inhibitors market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:

  • AbbVie Inc.
  • Celgene Corp. (NASDAQ: CELG)
  • Johnson & Johnson Services Inc. (NYSE: JNJ)
  • The Takeda Pharmaceutical Company Limited
  • Others

The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter’s five forces.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Product
  • Region
Breakup by Product
  • Velcade
  • Kyprolis
  • Ninlaro
  • Others
Breakup by Region
  • North America
    • United States of America 
    • Canada
  • Europe
    • United Kingdom
    • Germany
    • France
    • Italy
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • ASEAN
    • Australia
    • Others
  • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • United Arab Emirates
    • Nigeria
    • South Africa
    • Others
Market Dynamics
  • SWOT Analysis
  • Porter's Five Forces Analysis
  • Key Indicators for Demand
  • Key Indicators for Price
Competitive Landscape
  • Market Structure
  • Company Profiles
    • Company Overview
    • Product Portfolio
    • Demographic Reach and Achievements
    • Certifications
Companies Covered
  • AbbVie Inc.
  • Celgene Corporation
  • Johnson & Johnson Services Inc.
  • The Takeda Pharmaceutical Company Limited
  • Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Opportunities and Challenges in the Market
8    Global Proteasome Inhibitors Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Proteasome Inhibitors Historical Market (2018-2023) 
    8.3    Global Proteasome Inhibitors Market Forecast (2024-2032)
    8.4    Global Proteasome Inhibitors Market by Product
        8.4.1    Velcade
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)  
        8.4.2    Kyprolis
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
        8.4.3    Ninlaro
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
        8.4.4    Others    
    8.5    Global Proteasome Inhibitors Market by Region
        8.5.1    North America
            8.5.1.1    Historical Trend (2018-2023) 
            8.5.1.2    Forecast Trend (2024-2032)
        8.5.2    Europe
            8.5.2.1    Historical Trend (2018-2023) 
            8.5.2.2    Forecast Trend (2024-2032)
        8.5.3    Asia Pacific
            8.5.3.1    Historical Trend (2018-2023) 
            8.5.3.2    Forecast Trend (2024-2032)
        8.5.4    Latin America
            8.5.4.1    Historical Trend (2018-2023) 
            8.5.4.2    Forecast Trend (2024-2032)
        8.5.5    Middle East and Africa
            8.5.5.1    Historical Trend (2018-2023) 
            8.5.5.2    Forecast Trend (2024-2032) 
9    North America Proteasome Inhibitors Market Analysis
    9.1    United States of America 
        9.1.1    Historical Trend (2018-2023) 
        9.1.2    Forecast Trend (2024-2032)
    9.2    Canada
        9.2.1    Historical Trend (2018-2023) 
        9.2.2    Forecast Trend (2024-2032)
10    Europe Proteasome Inhibitors Market Analysis
    10.1    United Kingdom
        10.1.1    Historical Trend (2018-2023) 
        10.1.2    Forecast Trend (2024-2032)
    10.2    Germany
        10.2.1    Historical Trend (2018-2023) 
        10.2.2    Forecast Trend (2024-2032)
    10.3    France
        10.3.1    Historical Trend (2018-2023) 
        10.3.2    Forecast Trend (2024-2032)
    10.4    Italy
        10.4.1    Historical Trend (2018-2023) 
        10.4.2    Forecast Trend (2024-2032)
    10.5    Others
11    Asia Pacific Proteasome Inhibitors Market Analysis
    11.1    China
        11.1.1    Historical Trend (2018-2023) 
        11.1.2    Forecast Trend (2024-2032)
    11.2    Japan
        11.2.1    Historical Trend (2018-2023) 
        11.2.2    Forecast Trend (2024-2032)
    11.3    India
        11.3.1    Historical Trend (2018-2023) 
        11.3.2    Forecast Trend (2024-2032)
    11.4    ASEAN
        11.4.1    Historical Trend (2018-2023) 
        11.4.2    Forecast Trend (2024-2032)
    11.5    Australia
        11.5.1    Historical Trend (2018-2023) 
        11.5.2    Forecast Trend (2024-2032)
    11.6    Others
12    Latin America Proteasome Inhibitors Market Analysis
    12.1    Brazil
        12.1.1    Historical Trend (2018-2023) 
        12.1.2    Forecast Trend (2024-2032)
    12.2    Argentina
        12.2.1    Historical Trend (2018-2023) 
        12.2.2    Forecast Trend (2024-2032)
    12.3    Mexico
        12.3.1    Historical Trend (2018-2023) 
        12.3.2    Forecast Trend (2024-2032)
    12.4    Others
13    Middle East and Africa Proteasome Inhibitors Market Analysis
    13.1    Saudi Arabia
        13.1.1    Historical Trend (2018-2023) 
        13.1.2    Forecast Trend (2024-2032)
    13.2    United Arab Emirates
        13.2.1    Historical Trend (2018-2023) 
        13.2.2    Forecast Trend (2024-2032)
    13.3    Nigeria
        13.3.1    Historical Trend (2018-2023) 
        13.3.2    Forecast Trend (2024-2032)
    13.4    South Africa
        13.4.1    Historical Trend (2018-2023) 
        13.4.2    Forecast Trend (2024-2032)
    13.5    Others
14    Market Dynamics
    14.1    SWOT Analysis
        14.1.1    Strengths
        14.1.2    Weaknesses
        14.1.3    Opportunities
        14.1.4    Threats
    14.2    Porter’s Five Forces Analysis
        14.2.1    Supplier’s Power
        14.2.2    Buyer’s Power
        14.2.3    Threat of New Entrants
        14.2.4    Degree of Rivalry
        14.2.5    Threat of Substitutes
    14.3    Key Indicators for Demand
    14.4    Key Indicators for Price
15    Value Chain Analysis
16    Competitive Landscape

    16.1    Market Structure
    16.2    Company Profiles
        16.2.1    AbbVie Inc.
            16.2.1.1    Company Overview
            16.2.1.2    Product Portfolio
            16.2.1.3    Demographic Reach and Achievements
            16.2.1.4    Certifications
        16.2.2    Celgene Corporation
            16.2.2.1    Company Overview
            16.2.2.2    Product Portfolio
            16.2.2.3    Demographic Reach and Achievements
            16.2.2.4    Certifications
        16.2.3    Johnson & Johnson Services Inc.
            16.2.3.1    Company Overview
            16.2.3.2    Product Portfolio
            16.2.3.3    Demographic Reach and Achievements
            16.2.3.4    Certifications
        16.2.4    The Takeda Pharmaceutical Company Limited
            16.2.4.1    Company Overview
            16.2.4.2    Product Portfolio
            16.2.4.3    Demographic Reach and Achievements
            16.2.4.4    Certifications
        16.2.5    Others
17    Key Trends and Developments in the Market


List of Key Figures and Tables

1.    Global Proteasome Inhibitors Market: Key Industry Highlights, 2018 and 2032
2.    Global Proteasome Inhibitors Historical Market: Breakup by Product (USD Million), 2018-2023
3.    Global Proteasome Inhibitors Market Forecast: Breakup by Product (USD Million), 2024-2032
4.    Global Proteasome Inhibitors Historical Market: Breakup by Region (USD Million), 2018-2023
5.    Global Proteasome Inhibitors Market Forecast: Breakup by Region (USD Million), 2024-2032
6.    North America Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2018-2023
7.    North America Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2024-2032
8.    Europe Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2018-2023
9.    Europe Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2024-2032
10.    Asia Pacific Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2018-2023
11.    Asia Pacific Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2024-2032
12.    Latin America Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2018-2023
13.    Latin America Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2024-2032
14.    Middle East and Africa Proteasome Inhibitors Historical Market: Breakup by Country (USD Million), 2018-2023
15.    Middle East and Africa Proteasome Inhibitors Market Forecast: Breakup by Country (USD Million), 2024-2032
16.    Global Proteasome Inhibitors Market Structure

Key Questions Answered in the Report

The global proteasome inhibitors market is projected to grow at a CAGR of 8.6% between 2023 and 2032.

The market is estimated to grow in the forecast period of 2024-2032 to reach about USD 3.77 billion by 2032.

The major drivers of the industry, such as the growing demand for proteasome inhibitors in the medical sector, growing incidences of cancer across the globe, increased government investment to develop the healthcare sector, and the growing technological advancements, are expected to aid the market growth.

The key market trends guiding the growth of the industry include the growing research and development activities and a rise in the number of clinical trials being conducted globally.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific, with North America accounting for the largest share in the market.

Velcade, kyprolis, and ninlaro, among others, are the leading proteasome inhibitors products in the industry.

The major players in the industry are AbbVie Inc., Celgene Corp. (NASDAQ: CELG), Johnson & Johnson Services Inc. (NYSE: JNJ), The Takeda Pharmaceutical Company Limited, Others.

Analyst Review

The global proteasome inhibitors market is being driven by the rising prevalence of cancer and advancing medical sector. Aided by the increased focus on research and development activities, the market is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 8.6%. The proteasome inhibitors market is projected to reach USD 3.77 billion by 2032.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the industry can be segmented into velcade, kyprolis, and ninlaro, among others. The major regional markets for proteasome inhibitors are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa, with North America accounting for the largest share of the market. The key players in the above market include AbbVie Inc., Celgene Corp. (NASDAQ: CELG), Johnson & Johnson Services Inc. (NYSE: JNJ), The Takeda Pharmaceutical Company Limited, Others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2969     $2699
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5499     $4999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 6599     $5999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 7699     $6999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER